Adirondack Trust Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Adirondack Trust Company’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$91K	Buy	575 +100	+21%	+$13.5K	0.03%	212
2026 Q1	$60.7K	Hold	475	–	–	0.02%	238
2025 Q4	$57.9K	Sell	475 -30	-6%	-$3.44K	0.02%	236
2025 Q3	$50.6K	Hold	505	–	–	0.02%	254
2025 Q2	$41.9K	Sell	505 -695	-58%	-$55.4K	0.02%	256
2025 Q1	$97.3K	Sell	1,200 -40	-3%	-$3.58K	0.04%	186
2024 Q4	$112K	Sell	1,240 -150	-11%	-$14.5K	0.04%	176
2024 Q3	$137K	Hold	1,390	–	–	0.05%	163
2024 Q2	$129K	Hold	1,390	–	–	0.05%	166
2024 Q1	$132K	Hold	1,390	–	–	0.06%	166
2023 Q4	$137K	Sell	1,390 -1,105	-44%	-$82.1K	0.06%	161
2023 Q3	$182K	Sell	2,495 -4,060	-62%	-$324K	0.09%	134
2023 Q2	$553K	Hold	6,555	–	–	0.26%	82
2023 Q1	$500K	Hold	6,555	–	–	0.25%	85
2022 Q4	$544K	Hold	6,555	–	–	0.28%	80
2022 Q3	$520K	Hold	6,555	–	–	0.29%	78
2022 Q2	$487K	Sell	6,555 -110	-2%	-$8.26K	0.26%	82
2022 Q1	$599K	Hold	6,665	–	–	0.28%	75
2021 Q4	$746K	Hold	6,665	–	–	0.36%	69
2021 Q3	$832K	Sell	6,665 -170	-2%	-$21.9K	0.4%	63
2021 Q2	$925K	Sell	6,835 -40	-0.6%	-$5.26K	0.47%	54
2021 Q1	$933K	Hold	6,875	–	–	0.5%	47
2020 Q4	$1.05M	Buy	6,875 +1,070	+18%	+$137K	0.63%	40
2020 Q3	$647K	Hold	5,805	–	–	0.42%	57
2020 Q2	$635K	Buy	5,805 +200	+4%	+$19.7K	0.42%	56
2020 Q1	$434K	Buy	5,605 +360	+7%	+$31.9K	0.35%	65
2019 Q4	$467K	Hold	5,245	–	–	0.31%	70
2019 Q3	$400K	Sell	5,245 -150	-3%	-$12.5K	0.28%	71
2019 Q2	$473K	Hold	5,395	–	–	0.33%	62
2019 Q1	$460K	Hold	5,395	–	–	0.32%	65
2018 Q4	$387K	Sell	5,395 -500	-8%	-$40.3K	0.3%	65
2018 Q3	$565K	Buy	5,895 +2,500	+74%	+$242K	0.38%	58
2018 Q2	$323K	Hold	3,395	–	–	0.23%	77
2018 Q1	$295K	Buy	3,395 +1,500	+79%	+$137K	0.21%	80
2017 Q4	$161K	Hold	1,895	–	–	0.12%	105
2017 Q3	$164K	Hold	1,895	–	–	0.13%	100
2017 Q2	$146K	Sell	1,895 -4,000	-68%	-$284K	0.12%	105
2017 Q1	$409K	Sell	5,895 -415	-7%	-$27.9K	0.29%	68
2016 Q4	$373K	Buy	6,310 +4,660	+282%	+$288K	0.26%	73
2016 Q3	$109K	Hold	1,650	–	–	0.08%	117
2016 Q2	$89K	Hold	1,650	–	–	0.06%	141
2016 Q1	$85K	Hold	1,650	–	–	0.06%	131
2015 Q4	$83K	Buy	1,650 +1,575	+2,100%	+$107K	0.07%	126
2015 Q3	$5K	Hold	75	–	–	﹤0.01%	287
2015 Q2	$6K	Hold	75	–	–	﹤0.01%	286
2015 Q1	$6K	Buy	+75	New	+$5.24K	﹤0.01%	291

Other funds holding XBI

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

PSP Research Newtown Square, Pennsylvania $188M AUM

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

MFS

Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

LHWM

Lake Hills Wealth Management Austin, Texas $220M AUM 39.11% 1-Year Est. Return

MWA

MFA Wealth Advisors Pittsburgh, Pennsylvania $587M AUM 27.44% 1-Year Est. Return

Adirondack Trust Company's XBI Position: Q2 2026 in Review

Adirondack Trust Company increased its State Street SPDR S&P Biotech ETF (XBI) stake by 21% in Q2 2026, buying an estimated $13.5K and bringing the position to 575 shares worth $91K. The position accounts for 0.03% of the portfolio, ranked #212.

Adirondack Trust Company first reported a position in XBI in Q1 2015 and has held it in 46 quarters since. The position peaked at $1.05M in Q4 2020. 152 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Adirondack Trust Company held 575 shares of State Street SPDR S&P Biotech ETF worth $91K as of Q2 2026.
Adirondack Trust Company bought 100 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $13.5K.
State Street SPDR S&P Biotech ETF made up 0.03% of Adirondack Trust Company's portfolio in Q2 2026, its #212 holding.
Adirondack Trust Company first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and has held it in 46 quarters since.
Adirondack Trust Company's State Street SPDR S&P Biotech ETF position peaked at $1.05M in Q4 2020.
152 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.